- Home
- OOMA vs TNGX Comparison
OOMA vs TNGX Comparison
Compare OOMA & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OOMA
- TNGX
- Stock Information
- Founded
- OOMA 2003
- TNGX 2014
- Country
- OOMA United States
- TNGX United States
- Employees
- OOMA N/A
- TNGX N/A
- Industry
- OOMA EDP Services
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- OOMA Technology
- TNGX Health Care
- Exchange
- OOMA Nasdaq
- TNGX Nasdaq
- Market Cap
- OOMA 379.7M
- TNGX 317.4M
- IPO Year
- OOMA 2015
- TNGX N/A
- Fundamental
- Price
- OOMA $13.03
- TNGX $1.33
- Analyst Decision
- OOMA Buy
- TNGX Strong Buy
- Analyst Count
- OOMA 6
- TNGX 7
- Target Price
- OOMA $17.63
- TNGX $12.33
- AVG Volume (30 Days)
- OOMA 159.0K
- TNGX 789.1K
- Earning Date
- OOMA 03-04-2025
- TNGX 05-07-2025
- Dividend Yield
- OOMA N/A
- TNGX N/A
- EPS Growth
- OOMA N/A
- TNGX N/A
- EPS
- OOMA N/A
- TNGX N/A
- Revenue
- OOMA $256,851,999.00
- TNGX $42,069,000.00
- Revenue This Year
- OOMA $7.98
- TNGX N/A
- Revenue Next Year
- OOMA $7.97
- TNGX N/A
- P/E Ratio
- OOMA N/A
- TNGX N/A
- Revenue Growth
- OOMA 8.50
- TNGX 15.17
- 52 Week Low
- OOMA $6.50
- TNGX $1.33
- 52 Week High
- OOMA $17.00
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- OOMA 38.25
- TNGX 25.02
- Support Level
- OOMA $12.60
- TNGX $1.48
- Resistance Level
- OOMA $13.99
- TNGX $1.66
- Average True Range (ATR)
- OOMA 0.37
- TNGX 0.15
- MACD
- OOMA -0.04
- TNGX -0.02
- Stochastic Oscillator
- OOMA 32.28
- TNGX 2.03
About OOMA Ooma Inc.
Ooma Inc is a communications services company. It is a smart software-as-a-service ("SaaS") and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. Ooma generates revenues from the sale of subscriptions and other services.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.